reckitt benckiser group plc - RBGPF

RBGPF

Close Chg Chg %
81.36 2.68 3.30%

Closed Market

84.04

+2.68 (3.30%)

Volume: 176.00

Last Updated:

Jan 15, 2026, 2:33 PM EDT

Company Overview: reckitt benckiser group plc - RBGPF

RBGPF Key Data

Open

$84.04

Day Range

84.04 - 84.04

52 Week Range

60.27 - 84.04

Market Cap

$54.83B

Shares Outstanding

671.81M

Public Float

642.57M

Beta

0.44

Rev. Per Employee

N/A

P/E Ratio

34.68

EPS

$3.84

Yield

326.59%

Dividend

$3.16

EX-DIVIDEND DATE

Feb 2, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

482.95

 

RBGPF Performance

1 Week
 
0.00%
 
1 Month
 
4.76%
 
3 Months
 
6.26%
 
1 Year
 
39.97%
 
5 Years
 
-3.08%
 

RBGPF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About reckitt benckiser group plc - RBGPF

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.

RBGPF At a Glance

Reckitt Benckiser Group Plc
Turner House
Slough, Berkshire SL1 3UH
Phone 44-1753-217800 Revenue 18.11B
Industry Household/Personal Care Net Income 1.82B
Sector Consumer Non-Durables Employees 51,460
Fiscal Year-end 12 / 2025
View SEC Filings

RBGPF Valuation

P/E Current 34.683
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 23.265
Price to Sales Ratio 2.346
Price to Book Ratio 4.954
Price to Cash Flow Ratio 12.39
Enterprise Value to EBITDA 10.427
Enterprise Value to Sales 2.885
Total Debt to Enterprise Value 0.208

RBGPF Efficiency

Revenue/Employee 351,832.931
Income Per Employee 35,409.257
Receivables Turnover 6.768
Total Asset Turnover 0.546

RBGPF Liquidity

Current Ratio 0.579
Quick Ratio 0.388
Cash Ratio 0.111

RBGPF Profitability

Gross Margin 60.484
Operating Margin 24.42
Pretax Margin 14.849
Net Margin 10.064
Return on Assets 5.514
Return on Equity 19.074
Return on Total Capital 9.501
Return on Invested Capital 9.887

RBGPF Capital Structure

Total Debt to Total Equity 129.243
Total Debt to Total Capital 56.378
Total Debt to Total Assets 34.224
Long-Term Debt to Equity 108.001
Long-Term Debt to Total Capital 47.112
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Reckitt Benckiser Group Plc - RBGPF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
18.20B 17.80B 18.16B 18.11B
Sales Growth
+1.43% -2.19% +1.99% -0.29%
Cost of Goods Sold (COGS) incl D&A
7.73B 7.54B 7.30B 7.15B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
590.01M 744.00M 584.23M 589.07M
Depreciation
408.47M 405.26M 451.23M 451.07M
Amortization of Intangibles
181.54M 338.74M 133.01M 138.00M
COGS Growth
+6.89% -2.37% -3.22% -2.02%
Gross Income
10.47B 10.26B 10.86B 10.95B
Gross Income Growth
-2.25% -2.05% +5.82% +0.88%
Gross Profit Margin
+57.54% +57.62% +59.79% +60.48%
2021 2022 2023 2024 5-year trend
SG&A Expense
6.64B 6.11B 6.73B 6.53B
Research & Development
430.47M 400.33M 418.91M 415.29M
Other SG&A
6.21B 5.71B 6.31B 6.11B
SGA Growth
+1.02% -8.01% +10.09% -2.96%
Other Operating Expense
- - - -
-
Unusual Expense
(977.84M) 167.52M 1.02B 1.31B
EBIT after Unusual Expense
4.81B 3.98B 3.10B 3.11B
Non Operating Income/Expense
(4.80B) 130.57M 275.96M 71.56M
Non-Operating Interest Income
41.26M 68.98M 63.40M 77.95M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
363.08M 328.89M 395.29M 491.96M
Interest Expense Growth
-13.68% -9.42% +20.19% +24.45%
Gross Interest Expense
363.08M 328.89M 395.29M 491.96M
Interest Capitalized
- - - -
-
Pretax Income
(353.45M) 3.78B 2.98B 2.69B
Pretax Income Growth
-114.71% +1,169.54% -21.05% -9.92%
Pretax Margin
-1.94% +21.23% +16.44% +14.85%
Income Tax
(286.06M) 875.80M 936.02M 858.69M
Income Tax - Current - Domestic
75.64M 155.20M 944.72M 849.75M
Income Tax - Current - Foreign
975.09M 760.01M 55.94M 44.72M
Income Tax - Deferred - Domestic
(1.34B) (39.42M) (64.64M) (35.78M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(71.52M) 2.90B 2.05B 1.83B
Minority Interest Expense
15.13M 23.40M 17.40M 2.56M
Net Income
(86.64M) 2.88B 2.03B 1.83B
Net Income Growth
-105.94% +3,422.41% -29.44% -10.04%
Net Margin Growth
-0.48% +16.17% +11.19% +10.09%
Extraordinaries & Discontinued Operations
- - 42.63M (5.11M)
-
Discontinued Operations
- - 42.63M (5.11M)
-
Net Income After Extraordinaries
(44.01M) 2.88B 2.03B 1.82B
Preferred Dividends
- - - -
-
Net Income Available to Common
(44.01M) 2.88B 2.03B 1.82B
EPS (Basic)
-0.0617 4.0245 2.834 2.6017
EPS (Basic) Growth
-102.88% +6,622.69% -29.58% -8.20%
Basic Shares Outstanding
713.76M 715.28M 716.70M 700.39M
EPS (Diluted)
-0.0617 4.0121 2.8278 2.5966
EPS (Diluted) Growth
-102.89% +6,602.59% -29.52% -8.18%
Diluted Shares Outstanding
713.76M 717.49M 718.28M 701.74M
EBITDA
4.42B 4.89B 4.71B 5.01B
EBITDA Growth
-6.77% +10.67% -3.66% +6.35%
EBITDA Margin
+24.28% +27.47% +25.95% +27.67%

Reckitt Benckiser Group Plc in the News